Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients
It is widely accepted that assessing circular tumor DNA (ctDNA) in the plasma of cancer patients is a promising practice to evaluate somatic mutations from solid tumors noninvasively. Recently, it was reported that isolation of extracellular vesicles improves the detection of mutant DNA from plasma...
Saved in:
Main Authors: | Silvia Galbiati (Author), Francesco Damin (Author), Dario Brambilla (Author), Lucia Ferraro (Author), Nadia Soriani (Author), Anna M. Ferretti (Author), Valentina Burgio (Author), Monica Ronzoni (Author), Riccardo Vago (Author), Laura Sola (Author), Marcella Chiari (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies
Published: (2020) -
Circulating cell-free DNA biomarkers
by: Jose Rafael Villarreal Escorcia
Published: (2021) -
Circulating DNA fragmentomics and cancer screening
by: A.R. Thierry
Published: (2023) -
Circulating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies
by: Daniel Wenzel, MD, et al.
Published: (2024) -
Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
by: Shethah R. Morgan, et al.
Published: (2012)